Behold.ai vs Qure AI (2026)
Two chest radiograph companies separated by the most consequential design decision in imaging AI: whether a human still looks. Behold auto reports films it classifies as high confidence normal, removing them from the worklist entirely, which is genuine autonomy inside a bounded task and one of the few instances of it in this index. Qure triages and flags across the broadest chest radiograph regulatory footprint in the market, and the radiologist still reads. The evidence bar should differ accordingly. An autonomous normal classifier needs its false negative rate at the operating threshold published and revalidated locally, because a missed finding on an auto reported film is seen by nobody, ever. Behold publishes more of those numbers than most, and its regulatory standing across jurisdictions is the thing to settle before deployment.
- It removes studies from the worklist entirely, classifying chest radiographs as high confidence normal and auto reporting them, which is genuine autonomy inside a deliberately bounded task.
- The performance numbers that matter for that autonomy are published in peer reviewed venues rather than asserted, and the confidence threshold is itself the governance mechanism.
- For a service drowning in normal chest films, removing them from the queue is a different economic proposition from reading them faster.
- The regulatory footprint across chest radiography is the broadest in the market, spanning nine products across radiography and computed tomography with published device dossiers.
- It is deployed where reading capacity is thinnest, including public health screening programmes, which is a harder operating environment than a hospital worklist.
- On premise installation is supported and stated, which removes the data transfer question rather than governing it.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Behold.ai and Qure AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Behold.ai its top capability grade on AI Centrality and Autonomy and Oversight Model. Set against Qure AI, Behold.ai grades higher on Autonomy and Oversight Model and EHR and Interoperability Depth. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Qure AI its top capability grade on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Set against Behold.ai, Qure AI grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Behold.ai or Qure AI?
On the axes where the AI Health Index separates them, Behold.ai grades higher on Autonomy and Oversight Model and EHR and Interoperability Depth, and Qure AI grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Qure AI leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Behold.ai and Qure AI differ most?
The widest separation the AI Health Index records between Behold.ai and Qure AI is on FDA and Regulatory Status, where Behold.ai grades C and Qure AI grades A. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Behold.ai and Qure AI grade the same?
The AI Health Index grades Behold.ai and Qure AI the same on several axes, including AI Centrality, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Behold.ai and Qure AI not disclosed?
At the last review, at least one of Behold.ai and Qure AI published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
The autonomy difference changes what evidence you should demand: a product that auto reports a study nobody reads needs its false negative rate at the operating threshold published and locally revalidated, because a missed finding is never seen by anyone, while a triage product leaves the radiologist reading every film.
Behold's regulatory standing is multi jurisdictional and unsettled, and its corporate history complicates the identity of the contracting entity, both of which should be established before deployment. Neither publishes pricing, and neither publishes performance stratified by prevalence.